Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Next-Generation Endocrine Therapies for Breast Cancer.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology - 20 Apr 2021

McDonnell Donald P, Wardell Suzanne E, Chang Ching-Yi, Norris John D

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Agents, Hormonal
Share to Breast Neoplasms
Share to Estrogen Receptor alpha
Share to Mutation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Selective Estrogen Receptor Modulators

Source

Open in PubMed Open full text

Identifiers

PMID: 33705209
DOI: 10.1200/JCO.20.03565
PMCID: PMC8274744

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Next-Generation Endocrine Therapies for Breast Cancer.PMID 33705209Read ↗

[Novel target therapies used in breast cancer management].Semantic proximity Read ↗

How I treat endocrine-dependent metastatic breast cancer.Semantic proximity Read ↗

Past, present, and future challenges in breast cancer treatment.Semantic proximity Read ↗

Targeted therapies for ER+/HER2- metastatic breast cancerSemantic proximity Read ↗

Update on the Treatment of Early-Stage Triple-Negative Breast CancerSemantic proximity Read ↗

New agents for endocrine resistance in breast cancer.Semantic proximity Read ↗

Pharmacogenomics of breast cancer therapy: An updateSemantic proximity Read ↗

Treatment options for patients with triple-negative breast cancer.Semantic proximity Read ↗

Tailored therapies for triple-negative breast cancer: current landscape and future perceptionsSemantic proximity Read ↗

Targeted and cytotoxic inhibitors used in the treatment of breast cancerSemantic proximity Read ↗

New drugs for breast cancer subtypes: Targeting driver pathways to overcome resistanceSemantic proximity Read ↗

Endocrine resistance in hormone-responsive breast cancer: mechanisms and therapeutic strategies.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.